NDC 69379-285

Remaxazon External Patch

Remaxazon External Patch

Remaxazon External Patch is a Topical Patch in the Human Prescription Drug category. It is labeled and distributed by Home Aide Diagnostics, Inc.. The primary component is Chondroitin Sulfate Sodium (bovine); Capsaicin; Lidocaine; Glucosamine.

Product ID69379-285_10e0247a-5ffe-064e-e054-00144ff8d46c
NDC69379-285
Product TypeHuman Prescription Drug
Proprietary NameRemaxazon External Patch
Generic NameRemaxazon External Patch
Dosage FormPatch
Route of AdministrationTOPICAL
Marketing Start Date2015-03-09
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameHome Aide Diagnostics, Inc.
Substance NameCHONDROITIN SULFATE SODIUM (BOVINE); CAPSAICIN; LIDOCAINE; GLUCOSAMINE
Active Ingredient Strength3 g/100g; g/100g; g/100g; g/100g
Pharm ClassesAmide Local Anesthetic [EPC],Amides [CS],Antiarrhythmic [EPC],Local Anesthesia [PE]
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 69379-285-15

5 PACKAGE in 1 BOX (69379-285-15) > 3 PATCH in 1 PACKAGE > 100 g in 1 PATCH
Marketing Start Date2015-03-09
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 69379-285-15 [69379028515]

Remaxazon External Patch PATCH
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-03-09
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
CHONDROITIN SULFATE SODIUM (BOVINE)3 g/100g

OpenFDA Data

SPL SET ID:10e0247a-5ffd-064e-e054-00144ff8d46c
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1605123
  • Pharmacological Class

    • Amide Local Anesthetic [EPC]
    • Amides [CS]
    • Antiarrhythmic [EPC]
    • Local Anesthesia [PE]

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.